| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Genetics and Carcinogenesis Laboratory, Cross Cancer Institute, Edmonton, Alberta T6G 1Z2 [R. M., M. C. P.], and the Health Sciences Division, Chalk River Nuclear Laboratories, Chalk River, Ontario K0J 1J0 [B. P. S.], Canada
Dermal fibroblast strains from ataxia-telangiectasia (AT) patients and clinically normal subjects were exposed to 4-nitroquinoline 1-oxide (4NQO) or its 3-methyl derivative (3me4NQO), and their colony-forming abilities and DNA metabolic properties were compared. Three AT strains, i.e., AT2BE and AT3BI representing genetic complementation group AB and AT4BI belonging to group C, displayed enhanced (2.4- to 2.8-fold) sensitivity to reproductive inactivation by 4NQO, but exhibited normal survival in response to 3me4NQO. The initial induction and subsequent enzymatic repair of alkali-labile lesions (i.e., damaged sites converted to single-strand breaks in alkali) were quantitated by conventional velocity sedimentation analysis of cellular DNA in alkaline sucrose gradients. On exposure to concentrations of each chemical that produced comparable amounts of DNA damage, AT and normal cells removed alkali-labile lesions at similar rates. However, the three 4NQO-sensitive AT strains appeared to be defective in acting on alkali-stable adducts (formed by the parent compound but not its derivative), as judged by strand-break accumulation during posttreatment incubation with 1-ß-D-arabinofuranosylcytosine (araC). Specifically, the number of araC-detectable sites repaired in these AT strains during the critical 2-h period immediately following 4NQO treatment ranged from 40 to 60% of that processed by normal controls. AT5BI, a fourth AT strain assigned to complementation group D, responded normally to 4NQO-induced cytotoxicity and removed both alkali-labile and alkali-stable (araC-detectable) lesions normally. We thus conclude that the hypersensitivity of AT2BE, AT3BI, and AT4BI strains to 4NQO may be attributed, at least in part, to faulty execution of the excision-repair process operative on alkali-stable 4NQO adducts.
1 Supported initially by Atomic Energy of Canada Limited and the U. S. National Cancer Institute through Contract NO1-CP-21029 (Basic) with the Clinical and Environmental Epidemiology Branches, Bethesda, MD, and in the later stages by research grants from the National Cancer Institute of Canada and the Ataxia-Telangiectasia Medical Research Foundation and by Medical Scientist (M. C. P.) and Postdoctoral Fellowship (R. M.) awards from the Alberta Heritage Foundation for Medical Research.
2 To whom requests for reprints should be addressed, at Molecular Genetics and Carcinogensis Laboratory, Cross Cancer Institute, 11560 University Avenue, Edmonton, Alberta T6G 1Z2, Canada.
Received 3/30/88. Revised 12/12/88. Revised 7/ 5/89. Accepted 7/ 6/89.
This article has been cited by other articles:
![]() |
Y. Arima, C. Nishigori, T. Takeuchi, S. Oka, K. Morimoto, A. Utani, and Y. Miyachi 4-Nitroquinoline 1-Oxide Forms 8-Hydroxydeoxyguanosine in Human Fibroblasts through Reactive Oxygen Species Toxicol. Sci., June 1, 2006; 91(2): 382 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fritz, A. A. Friedl, R. M. Zwacka, F. Eckardt-Schupp, and M. S. Meyn The Yeast TEL1 Gene Partially Substitutes for Human ATM in Suppressing Hyperrecombination, Radiation-Induced Apoptosis and Telomere Shortening in A-T Cells Mol. Biol. Cell, August 1, 2000; 11(8): 2605 - 2616. [Abstract] [Full Text] |
||||
![]() |
R. Mirzayans, S. Bashir, D. Murray, and M. C. Paterson Inverse correlation between p53 protein levels and DNA repair efficiency in human fibroblast strains treated with 4-nitroquinoline 1-oxide: evidence that lesions other than DNA strand breaks trigger the p53 response Carcinogenesis, June 1, 1999; 20(6): 941 - 946. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Heron-Milhavet, M. Karas, C. M. Goldsmith, B. J. Baum, and D. LeRoith Insulin-like Growth Factor-I (IGF-I) Receptor Activation Rescues UV-damaged Cells through a p38 Signaling Pathway. POTENTIAL ROLE OF THE IGF-I RECEPTOR IN DNA REPAIR J. Biol. Chem., May 18, 2001; 276(21): 18185 - 18192. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |